Viridian Therapeutics
(NASDAQ) VRDN
Viridian Therapeutics Financials at a Glance
Market Cap
$1.92B
Revenue (TTM)
$70.92M
Net Income (TTM)
-$360.59M
EPS (TTM)
-$3.76
P/E Ratio
-4.62
Dividend
$0.00
Beta (Volatility)
0.93 (Low)
Dividend
$0.00
Beta (Volatility)
0.93 (Low)
Price
$17.90
Volume
5,787,325.487
Open
$17.39
Price
$17.90
Volume
5,787,325.487
Open
$17.39
Previous Close
$17.90
Daily Range
$17.38 - $18.38
52-Week Range
$13.18 - $34.29
Estimated Earnings Date
Aug 5, 2026
Dividend
$0.00
Beta (Volatility)
0.93 (Low)
Price
$17.90
Volume
5,787,325.487
Open
$17.39
Previous Close
$17.90
Daily Range
$17.38 - $18.38
52-Week Range
$13.18 - $34.29
Estimated Earnings Date
Aug 5, 2026
VRDN News
VRDN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Viridian Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
252
CEO
Stephen Frank Mahoney, MBA
Website
www.viridiantherapeutics.comHeadquarters
Waltham, MA 02453, US
VRDN Financials
Key Financial Metrics (TTM)
Gross Margin
99.38%
Operating Margin
-543.86%
Net Income Margin
-508.46%
Return on Equity
-60.70%
Return on Capital
-47.02%
Return on Assets
-45.70%
Earnings Yield
-21.65%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.92B
Shares Outstanding
110.43M
Volume
5.79M
Avg. Volume
2.90M
Financials (TTM)
Gross Profit
$70.48M
Operating Income
-$385.70M
EBITDA
-$349.44M
Operating Cash Flow
-$303.39M
Capital Expenditure
-$432.00K
Free Cash Flow
-$303.82M
Cash & ST Invst.
$762.18M
Total Debt
$51.17M
Viridian Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$141.00K
+95.8%
Gross Profit
$20.00K
-72.2%
Gross Margin
14.18%
N/A
Market Cap
$1.92B
N/A
Market Cap/Employee
$13.43M
N/A
Employees
143
N/A
Net Income
-$104.90M
-20.7%
EBITDA
-$101.32M
-17.5%
Quarterly Fundamentals
Total Cash
$762.18M
+19.7%
Total Debt
$51.17M
+141.1%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$50.44M
+143.8%
Short Term Debt
$738.00K
+37.7%
Return on Assets
-45.70%
N/A
Return on Invested Capital
-52.32%
N/A
Free Cash Flow
-$119.68M
-29.0%
Operating Cash Flow
-$119.65M
-29.1%